Target intelligence / Profile preview

ACSS3 antisense RNA 1 (ACSS3-AS1)

Target: ACSS3-AS1
Molecular classification: Other

Overview

ACSS3 antisense RNA 1 (ACSS3-AS1) is an antisense non-coding RNA transcribed from the opposite strand of the ACSS3 gene locus[1]. There is currently very limited information on ACSS3-AS1 in public databases and biomedical literature, and it is not recognized as a protein-coding gene, therapeutic target, receptor, enzyme, transporter, or established biomarker. Most available data concern the protein-coding gene ACSS3 itself, not its antisense RNA. There appear to be no established aliases, disease roles, pharmacological interactions, or recognized biological functions attributed specifically to ACSS3-AS1. Therefore, ACSS3-AS1 should not be considered a canonical molecular target, and more information would be needed to determine any functional or clinical relevance[1].

Beyond the preview

Go deeper on ACSS3 antisense RNA 1 (ACSS3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACSS3 antisense RNA 1 (ACSS3-AS1).

Explore the full profile